Temporal Dynamics of the Primary Human T Cell Response to Yellow Fever Virus 17D As It Matures from an Effector- to a Memory-Type Response
暂无分享,去创建一个
J. K. Sandberg | H. Ljunggren | Veronica D. Gonzalez | J. Michaëlsson | M. Ivarsson | K. Blom | Monika Braun | K. Falconer | M. Moll | Martin A. Ivarsson | J. Sandberg | V. Gonzalez
[1] L. Fetler,et al. Regulatory T Cells Increase the Avidity of Primary CD8+ T Cell Responses and Promote Memory , 2012, Science.
[2] M. Robb,et al. Single-Cell Level Response of HIV-Specific and Cytomegalovirus-Specific CD4 T Cells Correlate With Viral Control in Chronic HIV-1 Subtype A Infection , 2012, Journal of acquired immune deficiency syndromes.
[3] A. Thiel,et al. The early cellular signatures of protective immunity induced by live viral vaccination , 2012, European journal of immunology.
[4] R. Inman,et al. Immunodominance: a pivotal principle in host response to viral infections. , 2012, Clinical immunology.
[5] Sean C. Bendall,et al. Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. , 2012, Immunity.
[6] J. C. Love,et al. Polyfunctional responses by human T cells result from sequential release of cytokines , 2011, Proceedings of the National Academy of Sciences.
[7] H. Ljunggren,et al. Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection , 2011, Journal of Virology.
[8] J. Heath,et al. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells , 2011, Nature Network Boston.
[9] B. Murphy,et al. Immune response to dengue virus and prospects for a vaccine. , 2011, Annual review of immunology.
[10] R. Ahmed,et al. Insights into human CD8+ T‐cell memory using the yellow fever and smallpox vaccines , 2011, Immunology and cell biology.
[11] Mario Roederer,et al. Relationship between Functional Profile of HIV-1 Specific CD8 T Cells and Epitope Variability with the Selection of Escape Mutants in Acute HIV-1 Infection , 2011, PLoS pathogens.
[12] Stuart Berman,et al. Sexually transmitted diseases treatment guidelines, 2010. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[13] M. Gershman,et al. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[14] Veronica D. Gonzalez,et al. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection. , 2010, Clinical immunology.
[15] C. Rice,et al. The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response1 , 2009, The Journal of Immunology.
[16] K. Komanduri,et al. Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production1 , 2009, The Journal of Immunology.
[17] Bali Pulendran,et al. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology , 2009, Nature Reviews Immunology.
[18] Barbara Rehermann,et al. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.
[19] Mario Roederer,et al. Emerging concepts in the immunopathogenesis of AIDS. , 2009, Annual review of medicine.
[20] Bastian R. Angermann,et al. Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses , 2008, The Journal of experimental medicine.
[21] J. Altman,et al. Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. , 2008, Immunity.
[22] H. Ljunggren,et al. Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets. , 2008, Journal of immunological methods.
[23] Morten Nielsen,et al. Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction , 2007, BMC Bioinformatics.
[24] A. Teixeira-Carvalho,et al. Activation/modulation of adaptive immunity emerges simultaneously after 17DD yellow fever first‐time vaccination: is this the key to prevent severe adverse reactions following immunization? , 2007, Clinical and experimental immunology.
[25] P. Klenerman,et al. Human Immunodeficiency Virus Type 1 (HIV-1)-Specific CD8+ TEMRA Cells in Early Infection Are Linked to Control of HIV-1 Viremia and Predict the Subsequent Viral Load Set Point , 2007, Journal of Virology.
[26] J. Yewdell,et al. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. , 2006, Immunity.
[27] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[28] Bali Pulendran,et al. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity , 2006, The Journal of experimental medicine.
[29] C. Rice,et al. Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes , 2005, The Journal of experimental medicine.
[30] O. Lund,et al. An integrative approach to CTL epitope prediction: A combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions , 2005, European journal of immunology.
[31] G. Pantaleo,et al. HIV-1-specific IFN-gamma/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] Victor Appay,et al. Lessons from the study of T-cell differentiation in persistent human virus infection. , 2004, Seminars in immunology.
[33] Todd M. Allen,et al. HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication , 2004, The Lancet.
[34] M. Massari,et al. Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C , 2002, Journal of Virology.
[35] B. Walker,et al. Comprehensive Analysis of CD8+-T-Cell Responses against Hepatitis C Virus Reveals Multiple Unpredicted Specificities , 2002, Journal of Virology.
[36] D. Richman,et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections , 2002, Nature Medicine.
[37] D. Nixon,et al. Functional Heterogeneity of Cytokines and Cytolytic Effector Molecules in Human CD8+ T Lymphocytes1 , 2001, The Journal of Immunology.
[38] S. Rowland-Jones,et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.
[39] D. Baarle,et al. Changes in the composition of circulating CD8+ T cell subsets during acute epstein-barr and human immunodeficiency virus infections in humans. , 2000, The Journal of infectious diseases.
[40] F. Sallusto,et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions , 1999, Nature.
[41] G. Ogg,et al. Direct Visualization of Antigen-specific CD8+T Cells during the Primary Immune Response to Epstein-Barr Virus In Vivo , 1998, The Journal of experimental medicine.
[42] J. Altman,et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.
[43] M. Bevan,et al. Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. , 1998, Immunity.
[44] R. O. Spertzel,et al. Yellow Fever Vaccine: Direct Challenge of Monkeys Given Graded Doses of 17D Vaccine , 1973, Applied microbiology.
[45] M. Theiler,et al. Modification of the virulence of yellow fever virus by cultivation in tissues in vitro , 1936 .
[46] U. Bauer,et al. [Centers for Disease Control and Prevention (CDC)]. , 2000, Annales de dermatologie et de venereologie.